Status:
NOT_YET_RECRUITING
Dietary Modification Intervention Involving Family Support (FamNUTRI) for Managing Sarcopenic Obesity Among Community-dwelling Older Adults
Lead Sponsor:
The Hong Kong Polytechnic University
Conditions:
Sarcopenic Obesity
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
The goal of this pilot RCT is to examine the feasibility and preliminary effects of a dietary modification intervention involving family support (FamNUTRI) on the management of sarcopenic obesity amon...
Eligibility Criteria
Inclusion
- older adults aged 65 years old or above who are living in the community and have not less than 4 shared meals with family weekly
- having a family member consent to offer support to the study participant
- diagnosed as having sarcopenic obesity using the diagnostic criteria of Asian Working Group for Sarcopenia (AWGS) for sarcopenia and definition from WHO for obesity for Asian, respectively: 3a)early-stage sarcopenia is defined by meeting one of the following criteria: low handgrip strength \<28 kg for men and \<18 kg for women, low appendicular skeletal muscle mass (ASM) /height2 \< 7 kg/m2 for men and \<5.7 kg/m2 for women, or low physical performance with a Short Physical Performance Battery (SPPB) score of \< 9; 3b) Obesity is defined by meeting one of the following criteria: BMI ≥25 kg/m2, waist circumference ≥ 90 cm in men and ≥ 80 cm in women, or percentage of body fat \>30%
- ability to read, write and understand Chinese without severe speaking, hearing and vision problems for intervention delivery.
Exclusion
- having any existing disease or condition that affects digestion or food intake, such as severe heart diseases, renal diseases, depression or advanced stages of cancer
- having medications that impact dietary patterns, digestion, or metabolism
- following specific dietary pattern or restrictions, such as diabetic diets and renal diets
- having alcohol addiction defined by Alcohol Use Disorders Identification Test (AUDIT) scoring 8 or above since it may affect their ability and their determination to make changes in dietary modification
- having medical implants such as a pacemaker since the equipment to carry out bioelectric impedance analysis (Inbody S10) may cause malfunctioning of the implanted devices.
Key Trial Info
Start Date :
April 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT06933823
Start Date
April 15 2025
End Date
May 1 2026
Last Update
April 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hong Kong Polytechnic University
Hong Kong, Hong Kong